Company profile BCYC

Bicycle Therapeutics Plc
bicycle therapeutics is a biotechnology company with big ambitions. we aim to revolutionise the pharmaceutical landscape with our disruptive technology and proprietary bicyclic peptide (bicycle®) product platform and to develop transformational new therapies for patients to improve future treatment options in oncology. bicycles, a new class of small molecular weight drug conju...gates for oncology and other diseases, are designed to have superior targeting abilities and to be more efficacious and better tolerated than existing drug conjugate modalities. they combine the properties of several therapeutic entities in a single modality, exhibiting the affinity and selective pharmacology associated with antibodies; the distribution kinetics of small molecules, allowing rapid tumor penetration; and the “tuneable” pharmacokinetic half-life and renal clearance of peptides, sparing cytotoxin-payload derived liver and gastrointestinal toxicity. our unique ip is based on the work of scientific foun Show More
Quarter analysis & expected interestLast update: February 08 2024 16:25:33.

After 39 days of this quarter the interest is at 50.0. Based on that we can calculate that during remaining 52 days it will total up to 117.0.
Bicycle Therapeutics expected interest is significantly higher compared to previous quarter (+101.7%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201999
129
30.3% QoQ
158
22.5% QoQ
87
-44.9% QoQ
2020 161
62.6% YoY 85.1% QoQ
135
4.7% YoY -16.1% QoQ
160
1.3% YoY 18.5% QoQ
49
-43.7% YoY -69.4% QoQ
2021 80
-50.3% YoY 63.3% QoQ
73
-45.9% YoY -8.8% QoQ
111
-30.6% YoY 52.1% QoQ
200
308.2% YoY 80.2% QoQ
2022 137
71.2% YoY -31.5% QoQ
247
238.4% YoY 80.3% QoQ
160
44.1% YoY -35.2% QoQ
115
-42.5% YoY -28.1% QoQ
2023 193
40.9% YoY 67.8% QoQ
267
8.1% YoY 38.3% QoQ
161
0.6% YoY -39.7% QoQ
58
-49.6% YoY -64.0% QoQ
2024 50
-74.1% YoY -13.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Bicycle Therapeutics search interestLast update: February 08 2024 16:25:33.
Correlation coefficient between keyword and revenue is 0.51
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 16:25:34.

The average 5 years interest of Bicycle Therapeutics was 10.84 per week.
The last year interest of Bicycle Therapeutics compared to the last 5 years has changed by 18.82%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 27.78%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Bicycle Therapeutics stock price to provide analysis

Correlation between past revenue and Bicycle Therapeutics stock price search interest

There is not enough data for Bicycle Therapeutics stock price to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Bicycle Therapeutics stock price to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Bicycle Therapeutics clinical trials to provide analysis

Correlation between past revenue and Bicycle Therapeutics clinical trials search interest

There is not enough data for Bicycle Therapeutics clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Bicycle Therapeutics clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BT1718 clinical trial to provide analysis

Correlation between past revenue and BT1718 clinical trial search interest

There is not enough data for BT1718 clinical trial to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BT1718 clinical trial to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BT5528 clinical trial to provide analysis

Correlation between past revenue and BT5528 clinical trial search interest

There is not enough data for BT5528 clinical trial to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BT5528 clinical trial to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BT8009 clinical trial to provide analysis

Correlation between past revenue and BT8009 clinical trial search interest

There is not enough data for BT8009 clinical trial to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BT8009 clinical trial to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Bicycle Therapeutics collaborations to provide analysis

Correlation between past revenue and Bicycle Therapeutics collaborations search interest

There is not enough data for Bicycle Therapeutics collaborations to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Bicycle Therapeutics collaborations to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Bicycle Therapeutics pipeline to provide analysis

Correlation between past revenue and Bicycle Therapeutics pipeline search interest

There is not enough data for Bicycle Therapeutics pipeline to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Bicycle Therapeutics pipeline to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Bicycle Therapeutics news to provide analysis

Correlation between past revenue and Bicycle Therapeutics news search interest

There is not enough data for Bicycle Therapeutics news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Bicycle Therapeutics news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Bicycle Therapeutics jobs to provide analysis

Correlation between past revenue and Bicycle Therapeutics jobs search interest

There is not enough data for Bicycle Therapeutics jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Bicycle Therapeutics jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for BCYC
Earnings date: 2024-02-26 After close
Company name: Bicycle Therapeutics Plc
Sector: Professional, Scientific, and Technical Services
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-04-30T11:00:00Z

BusinessWire
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

2026-04-21T14:31:00Z

BusinessWire
Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting

2026-04-20T11:00:00Z

BusinessWire
Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026

2026-04-08T13:29:23Z

Analyst Upgrades
Morgan Stanley Maintains Equal-Weight on Bicycle Therapeutics, Lowers Price Target to $12

2026-03-18T16:17:05Z

Analyst Upgrades
Oppenheimer Maintains Outperform on Bicycle Therapeutics, Lowers Price Target to $36

2026-03-18T14:03:05Z

Analyst Upgrades
RBC Capital Maintains Sector Perform on Bicycle Therapeutics, Lowers Price Target to $7

2026-03-18T12:47:06Z

Analyst Upgrades
Citizens Maintains Market Outperform on Bicycle Therapeutics, Lowers Price Target to $8

2026-03-18T11:00:00Z

BusinessWire
Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026

2026-03-18T10:00:28Z

Analyst Upgrades
Needham Maintains Buy on Bicycle Therapeutics, Lowers Price Target to $15

2026-03-17T11:00:00Z

BusinessWire
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results

2026-02-03T12:00:00Z

BusinessWire
Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline

2025-12-16T06:00:00Z

BusinessWire
Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline

2025-12-11T10:00:00-05:00

PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bicycle Therapeutics plc - BCYC

2025-11-24T17:54:14Z

Analyst Upgrades
Truist Securities Initiates Coverage On Bicycle Therapeutics with Hold Rating, Announces Price Target of $10

2025-11-20T10:00:00-05:00

PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bicycle Therapeutics plc - BCYC